Mirum Pharmaceuticals (MIRM) Asset Utilization Ratio (2021 - 2026)

Mirum Pharmaceuticals' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.66 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 17.9% year-over-year to 0.66; the TTM figure through Mar 2026 stood at 0.66 (up 17.9% YoY), while the FY2025 annual figure was 0.69, up 34.69% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.66, up from 0.64 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.66 in Q1 2026, with the low at 0.11 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.34 (2024), against an average of 0.39.
• The sharpest annual moves came in 2022 and 2026: Asset Utilization Ratio jumped 197.44% in 2022, then advanced 17.9% in 2026.
• Mirum Pharmaceuticals' Asset Utilization Ratio stood at 0.21 in 2022, then jumped by 33.72% to 0.29 in 2023, then surged by 75.17% to 0.5 in 2024, then climbed by 27.25% to 0.64 in 2025, then gained by 2.6% to 0.66 in 2026.
• Business Quant data shows MIRM's Asset Utilization Ratio at 0.66 in Q1 2026, 0.64 in Q4 2025, and 0.62 in Q3 2025.